The U.S. Food and Drug Administration is talking when they should be listening
On May 9-10, 2017, the U.S. Food and Drug Administration (FDA) held a workshop titled “Training health care providers on pain management and safe use of opioid analgesics — exploring the path forward.” I attended the workshop in person to offer comments on behalf of chronic pain patients. A summary of my observations at the time was published by the now-defunct Pain News Network. The following extended extract is from …
The U.S. Food and Drug Administration is talking when they should be listening







![Why early detection matters: Transforming lung cancer care [PODCAST]](https://kevinmd.com/wp-content/uploads/unnamed-2-7-190x100.jpg)

![Politics and fear have replaced science in U.S. pain management [PODCAST]](https://kevinmd.com/wp-content/uploads/Design-4-190x100.jpg)



